CLINICAL_TRIALS
trial_result
· 2019-08-02
Clinical Trial Update: European Phase III Study of APD421 in PONV [Phase 3]
Summary
Phase III trial of APD421 in postoperative nausea and vomiting has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Acacia Pharma Ltd | Conditions: PONV | Phase 3 | Status: COMPLETED | Results posted: 2019-08-02